COVID-19 vaccine delivery and distribution statement from MD Anderson

MD Anderson News Release December 13, 2020

The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration’s decision on Friday, Dec. 11, to grant Emergency Use Authorization. At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for use with frontline health care workers, which is scheduled for delivery on Monday, Dec. 14. Supplies needed to administer the vaccine were received last week.

MD Anderson’s initial vaccination clinics will safely and efficiently vaccinate health care workers caring for highly immune compromised patients and those with increased risk of occupational exposure. Vaccination clinics are scheduled to begin on Wednesday, Dec. 16. MD Anderson is committed to providing workforce members accurate information to help them decide whether and when to receive a COVID-19 vaccine. All safety precautions and current COVID-19 protocols, including masking, social distancing, handwashing and visitor limitations, continue to be required.

Due to COVID-19 precautions, all visitors, including media, are not allowed on campus. Photos and video content from the vaccine delivery will be made available on Monday.